Liver metastases of digestive endocrine tumours: Natural history and response to medical treatment

European Journal of Gastroenterology and Hepatology

Volumn 8, Issue 7, 1996, Pages 673-678

  Skinazi, Florence ^a   Zins, Marc ^a   Menu, Yves ^a   Bernades, Pierre ^a   Ruszniewski, Philippe ^a  

^a BEAUJON HOSPITAL   (France)

Author keywords

Carcinoid tumour; Chemoembolization; Chemotherapy; Digestive endocrine tumours; Gastrinoma; Liver metastases; Somatostatin analogues

Indexed keywords

ANGIOPEPTIN; CALCITONIN; FLUOROURACIL; OCTREOTIDE; SOMATOSTATIN DERIVATIVE; STREPTOZOCIN;

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CARCINOID; CLINICAL ARTICLE; DIGESTIVE SYSTEM TUMOR; ENDOCRINE TUMOR; FEMALE; FOLLOW UP; GASTRINOMA; HEPATIC ARTERY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIVER METASTASIS; MALE; PANCREAS TUMOR; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR VOLUME; WORLD HEALTH ORGANIZATION;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOID TUMOR; CHEMOEMBOLIZATION, THERAPEUTIC; DIGESTIVE SYSTEM NEOPLASMS; DISEASE PROGRESSION; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; GASTRINOMA; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; OCTREOTIDE; PEPTIDES, CYCLIC; SOMATOSTATIN; STREPTOZOCIN; TIME FACTORS; TREATMENT OUTCOME;

EID: 0029980223     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Mignon M, Ruszniewski P, Hochlaf S, Sobhani I, Cadiot G, Bonfils S, et al.: Quand proposer une transplantation hépatique (TH) aux patients avec métastases hépatiques (MH) de tumeurs endocrines (TE)? Gastroenterol Clin Biol 1991, A43.
2. Bonfils S, Mignon M: Tumeurs endocrines du pancréas. Paris: Doin Editeurs; 1987.
3. Norton JA, Sugarbaker PH, Doppman JL, Wesley RA, Maton PN, Gardner OD, et al.: Aggressive resection of metastatic disease in selected patients with malignant gastrinoma. Ann Surg 1986, 203:352-359.
4. Eriksson B, Skogseid B, Lundqvist G, Wide L, Wilander E, Oberg K: Medical treatment and long term survival in a prospective study of 84 patients with endocrine pancreatic tumors. Cancer 1990,65:1883-1890.
5. Mignon M, Ruszniewski P, Haffar S, Rigaud D, René E, Bonfils S: Current approach to the management of tumoral process in patients with gastrinoma. World J Surg 1986, 10:703-710.
6. Weber HC, Venzon DJ, Lin JT, Fishbein VA, Orbuch M, Strader DB, et al.: Determinants of metastatic rate and survival in patients with Zollinger-Ellison syndrome: a prospective long-term study. Gastroenterology 1995, 108:1637-1649.
7. McEntee GP, Nagorney DM, Kvols LK, Moertel CG, Grant CS: Cytoreductive hepatic surgery for neuroendocrine tumors. Surgery 1990, 108:1091-1096.
8. Carty SE, Jensen RT, Norton JA: Prospective study of aggressive resection of metastatic pancreatic endocrine tumors. Surgery 1992, 112:1026-1032.
9. Moertel CG, Hanley JA, Johnson LA: Streptozotocin alone compared with streptozotocin plus fluorouracil in the treatment of advanced islet-cell carcinoma. N Engl J Med 1980, 303:1189-1195.
10. Moertel CG, Lefkopoulo M, Lipsitz S, Hahn RG, Klaassen D: Streptozotocin-doxorubicin, streptozotocin-fluorouracil or chlorozotocin in the treatment of advanced islet cell carcinoma. N Engl J Med 1992, 326:519-523.
11. Von Schrenk T, Howard JM, Doppman JL, Norton JA, Maton PN, Smith FP, et al.: Prospective study of chemotherapy in patients with metastatic gastrinoma. Gastroenterology 1988, 94:1326-1334.
12. Arnold R, Frank M: Systemic chemotherapy for endocrine tumors of the pancreas: recent advances. In Endocrine Tumors of the Pancreas. Frontiers in Gastrointestinal Research, Vol 23. Edited by Mignon M, Jensen RT. Basel: Karger; 1995:431-438.
13. Moertel CG, Kvols LK, O'Connell MJ, Rubin J: Treatment of neuroendocrine carcinomas with combined etoposide and cisplatine. Evidence of major therapeutic activity in the anaplastic variants of these neoplasms. Cancer 1991, 68:227-232.
14. Ruszniewski P, Hochlaf S, Rougier P, Mignon M: Chimiothérapie intraveineuse par streptozotocine et 5 fluorouracile des métastases du syndrome de Zollinger-Ellison: étude prospective multicentrique chez 21 patients. Gastroenterol Clin Biol 1991, 15:393-398.
15. Ruszniewski P, Rougier P, Roche A, Legmann P, Sibert A, Hochlaf S, et al.: Hepatic arterial chemoembolization in patients with liver metastases of endocrine tumors. Cancer 1993, 71:2624-2630.
16. Mavligit GM, Pollock RE, Evans HL, Wallace S: Durable hepatic tumor regression after arterial chemoembolization-infusion in patients with islet cell carcinoma of the pancreas metastatic to the liver. Cancer 1993, 72:375-380.
17. Saltz L, Trochanowski B, Buckley M, Heffernan B, Niedzwiecki D, Tao Y, et al.: Octreotide as an antineoplastic agent in the treatment of functional and non functional neuroendocrine tumors. Cancer 1993, 72:244-248.
18. Gorden P, Comi RJ, Maton PN, Go VLW: Somatostatin and somatostatin analogue (SMS 201-995) in treatment of hormone secreting tumors of the pituitary and gastrointestinal tract and non-neoplastic diseases of the gut. Ann Intern Med 1989, 110:35-50.
19. Eriksson B, Öberg K, Alm C, Karlsson A, Lundqvist G, Andersson T, et al.: Treatment of malignant endocrine pancreatic tumors with human leukocyte interferon. Lancet 1990, ii:1307-1309.
20. Arnold R, Neuhaus C, Benning R, Schwerk WB, Trautmann ME, Joseph K, et al.: Somatostatin analog Sandostatin and inhibition of tumor growth in patients with metastatic endocrine gastroenteropancreatic tumors. World J Surg 1993, 17:511-519.
21. Carasco CH, Chuang VP, Wallace S: Apudomas metastatic to the liver: treatment by hepatic artery embolization. Radiology 1983, 149:79-83.
22. Arcenas AG, Ajani JA, Carrasco CH, Levin B, Wallace S: Vascular occlusive therapy of pancreatic endocrine tumors metastatic to the liver in endocrine tumors of the pancreas. In Frontiers in Gastrointestinal Research, Vol. 23. Edited by Mignon M, Jensen RT. Basel: Karger; 1995:439-450.
23. Allison DJ, Booth A: Arterial embolization in the management of liver metastases. Cardiovasc Intervent Radiol 1990, 13:161-168.
24. Reichlin S: Somatostatin. N Engl J Med 1983, 309:1495-1501.
25. Ch'ng JL, Anderson JV, Williams SJ, Carr DH, Bloom SR: Remission of symptoms during long term treatment of metastatic pancreatic endocrine tumors with long acting somatostatin analogues. BMJ 1986, 292:981-982.
26. Kvols LK, Moertel CG, O'Connell MJ, Schutt AJ, Rubin J, Hahn RG: Treatment of malignant carcinoid syndrome: evaluation of long acting somatostatin analogues. N Engl J Med 1986, 315:663-666.
27. Ruszniewski P, Rougier P, Rampal P, Grangé JD, Jian R, Treffot G, et al.: Does lanreotide influence the growth of metastatic carcinoid tumors? Gastroenterology 1994, 106:A319.